Skip to main content
. 2018 Jul 30;9:2982. doi: 10.1038/s41467-018-05384-1

Fig. 8.

Fig. 8

Immunocompatibility of D8-sLip. a, b Western blot assay (a) and quantification (b) of natural IgM on liposomal surface in vivo 1 and 4 h after injection. c Pharmacokinetic profiles of sLip, D8-sLip, and DCDX-sLip. d Biodistribution in liver and spleen of BALB/c mice of D8-sLip and DCDX-sLip. e IgG titrations. Absorbance in the ELISA plate versus serum dilution and antibody titer reported as log (EC50). D8-PEG3400-DSPE and DCDX-PEG3400-DSPE was used as antigens for D8-sLip and DCDX-sLip, respectively. f Absorbance in the ELISA plate for anti-PEG IgM evaluation. mPEG2000-DSPE was used as antigen for both formulations. n = 3, data are means ± s.d. Statistical significances were calculated by Student’s t-test. NS indicates not significant, *p < 0.05, **p < 0.01, ***p < 0.001